drugset / Trial / NCT04430959
Candesartan as an Adjunctive Treatment for Bipolar Depression
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study will assess the safety and tolerability of Candesartan when used in patients with Bipolar Disorder, in addition to their medication treatment.
Timeline
- Start
- 2020-10-01
- Primary completion
- 2022-07-01
- Completion
- 2022-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Candesartan | Unknown | 4 mg | Oral |